Skip to main content
SpringerLink
Log in

Polypill's cardiovascular and non-cardiovascular mortalities

  • Letter to the Editor
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. Br Med J. 2003;326(7404):1419–23.

    Article  CAS  Google Scholar 

  2. Roshandel G, Khoshnia M, Poustchi H, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet [Internet] 2019;394(10199):672–83. Available from: https://doi.org/10.1016/S0140-6736(19)31791-X

  3. Yusuf S, Joseph P, Dans A, et al. Polypill with or without Aspirin in Persons without Cardiovascular Disease. N Engl J Med. 2021;384(3):216–28.

    Article  CAS  Google Scholar 

  4. Huffman MD, Patel A. Polypills — A Central Strategy for Improving Cardiovascular Health. N Engl J Med [Internet] 2021;384(3):288–9. Available from: https://doi.org/10.1056/NEJMe2033310

  5. Ramos F. “Polypill” to fight cardiovascular disease: birthday present was much appreciated. BMJ [Internet] 2003;327(7418):808; discussion 809; author reply 809–10. Available from: http://europepmc.org/abstract/MED/14525892

Download references

Author information

Authors and Affiliations

  1. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Davood Khalili, Farzad Hadaegh & Marzieh Pirzadeh

  2. Bernard Lown Scholar in Cardiovascular Health, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Davood Khalili

  3. Department of Biostatistics and Epidemiology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 23, Arabi st, Velenjak, Tehran, Iran

    Davood Khalili

  4. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Fereidoun Azizi

Authors
  1. Davood Khalili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farzad Hadaegh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marzieh Pirzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fereidoun Azizi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Davood Khalili.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khalili, D., Hadaegh, F., Pirzadeh, M. et al. Polypill's cardiovascular and non-cardiovascular mortalities. J Diabetes Metab Disord 20, 2133–2134 (2021). https://doi.org/10.1007/s40200-021-00885-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-021-00885-1

Search

Navigation